Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma.
First Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.
Y
Y
Muto
H
H
Moriwaki
Y
Y
Shiratori
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000556:secondary*; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology*; D016609:Neoplasms, Second Primary / Q000517:prevention & control*; D014212:Tretinoin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014212:Tretinoin; C034534:3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid